Baird Financial Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.4K | Hold |
|
|||||
|
2025
Q2 | $77.9K | Hold |
|
|||||
|
2025
Q1 | $41.1K | Buy |
|
|||||
|
2024
Q4 | $33K | Hold |
|
|||||
|
2024
Q3 | $23K | Hold |
|
|||||
|
2024
Q2 | $17.7K | Buy |
|
|||||
|
2024
Q1 | $28.8K | Buy |
|
|||||
|
2023
Q4 | $15.8K | Hold |
|
|||||
|
2023
Q3 | $14.5K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $202K | Buy |
|